<DOC>
	<DOCNO>NCT00028795</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Giving chemotherapy together radiation therapy may kill tumor cell . PURPOSE : This phase II trial study well give chemotherapy together radiation therapy surgery follow chemotherapy alone work child newly diagnose astrocytoma , glioblastoma multiforme , gliosarcoma , diffuse intrinsic pontine glioma .</brief_summary>
	<brief_title>Chemotherapy Radiation Therapy After Surgery Treating Children With Newly Diagnosed Astrocytoma , Glioblastoma Multiforme , Gliosarcoma , Diffuse Intrinsic Pontine Glioma</brief_title>
	<detailed_description>OBJECTIVES : - Compare event-free survival patient newly diagnose anaplastic astrocytoma , glioblastoma multiforme , gliosarcoma , diffuse intrinsic pontine glioma ( DIPG ) treat adjuvant temozolomide administer concurrently postoperative radiotherapy alone maintenance therapy vs historical control cohort treat prior Pediatric Oncology Group Children 's Cancer Group study . - Determine toxicity regimen patient . - Determine efficacy regimen patient DIPG . - Determine toxicity regimen patient DIPG . OUTLINE : This multicenter study . - Adjuvant chemoradiotherapy : Beginning within 6 week surgical resection diagnosis* , patient without gross residual disease undergo cranial irradiation 5 day week 6 week . Beginning within 6 week surgical resection , patient gross residual disease undergo radiotherapy follow boost radiotherapy 1 week . All patient receive oral temozolomide daily begin within 5 day initiation radiotherapy continue total 6 week absence disease progression unacceptable toxicity . - Adjuvant maintenance therapy : Beginning 4 week completion adjuvant chemoradiotherapy , patient receive oral temozolomide day 1-5 . Treatment repeat every 28 day total 10 course absence disease progression unacceptable toxicity . NOTE : *For patient diffuse intrinsic pontine glioma Patients follow every 3-6 month 4 year annually thereafter . PROJECTED ACCRUAL : A total 50-60 patient accrue study within 12-14 month .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm newly diagnose CNS tumor follow type : High grade glioma ( HGG ) one follow histology : Anaplastic astrocytoma ( grade III ) Glioblastoma multiforme ( grade IV ) Gliosarcoma Primary spinal cord malignant glioma Diffuse intrinsic pontine glioma ( DIPG ) Diagnosed gadoliniumenhanced MRI At least 2/3 tumor situate pons AND tumor clearly originate pons No diffuse leptomeningeal disease No tumor feature typical diffuse intrinsic brainstem glioma , include follow : Dorsally exophytic brainstem glioma Cervicomedullary junction tumor Focal lowgrade glioma midbrain brainstem No diffuse brainstem enlargement due neurofibromatosis No primary brain stem malignant glioma No M+ disease ( CSF positive tumor metastatic disease ) Must begin study radiotherapy within 6 week surgical resection ( HGG patient ) diagnosis ( DIPG patient ) PATIENT CHARACTERISTICS : Age : 3 21 Performance status : Karnofsky 50100 % OR Lansky 50100 % Life expectancy : At least 2 month Hematopoietic : Absolute neutrophil count least 1,000/mm^3 Platelet count least 100,000/mm^3* Hemoglobin least 10.0 g/dL* NOTE : *Transfusion independent Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) SGOT SGPT less 2.5 time ULN Renal : Creatinine great 1.5 time ULN Other : No concurrent malignancy Concurrent seizure disorder allow well control anticonvulsant Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 2 month completion study treatment PRIOR CONCURRENT THERAPY : Biologic : No concurrent routine cytokine support Chemotherapy : Not specify Endocrine therapy : No concurrent corticosteroids except increase intracranial pressure patient CNS tumor Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics Other : No prior therapy HGG DIPG</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>childhood brain stem glioma</keyword>
	<keyword>childhood high-grade cerebral astrocytoma</keyword>
	<keyword>childhood spinal cord neoplasm</keyword>
	<keyword>untreated childhood brain stem glioma</keyword>
</DOC>